BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Vonghia L, Francque S. Cross talk of the immune system in the adipose tissue and the liver in non-alcoholic steatohepatitis: Pathology and beyond. World J Hepatol 2015; 7(15): 1905-1912 [PMID: 26244065 DOI: 10.4254/wjh.v7.i15.1905]
URL: https://www.wjgnet.com/1948-5182/full/v7/i15/1905.htm
Number Citing Articles
A. L. L. Rocha, L. C. Faria, T. C. M. Guimarães, G. V. Moreira, A. L. Cândido, C. A. Couto, F. M. Reis. Non-alcoholic fatty liver disease in women with polycystic ovary syndrome: systematic review and meta-analysisJournal of Endocrinological Investigation 2017; 40(12): 1279 doi: 10.1007/s40618-017-0708-9
Marta Iruarrizaga-Lejarreta, Fernando Bril, Mazen Noureddin, Pablo Ortiz, Shelly C. Lu, José M. Mato, Cristina Alonso. Translational Research Methods in Diabetes, Obesity, and Nonalcoholic Fatty Liver Disease2019; : 423 doi: 10.1007/978-3-030-11748-1_16
Tereza C. M. Fontes-Cal, Rafael T. Mattos, Nayara I. Medeiros, Bruna F. Pinto, Mayara Belchior-Bezerra, Bruna Roque-Souza, Walderez O. Dutra, Teresa C. A. Ferrari, Paula V. T. Vidigal, Luciana C. Faria, Cláudia A. Couto, Juliana A. S. Gomes. Crosstalk Between Plasma Cytokines, Inflammation, and Liver Damage as a New Strategy to Monitoring NAFLD ProgressionFrontiers in Immunology 2021; 12 doi: 10.3389/fimmu.2021.708959
Joselyn N. Allen, Adwitia Dey, Jingwei Cai, Jingtao Zhang, Yuan Tian, Mary Kennett, Yanling Ma, T. Jake Liang, Andrew D. Patterson, Pamela A. Hankey-Giblin. Metabolic Profiling Reveals Aggravated Non-Alcoholic Steatohepatitis in High-Fat High-Cholesterol Diet-Fed Apolipoprotein E-Deficient Mice Lacking Ron Receptor SignalingMetabolites 2020; 10(8): 326 doi: 10.3390/metabo10080326
Mirella Pastore, Alessandra Gentilini, Fabio Marra. Non-Alcoholic Fatty Liver Disease2020; : 97 doi: 10.1007/978-3-319-95828-6_6
Yang Yang, Xian Liu, Hui Chen, Pengjun Wang, Songhui Yao, Bin Zhou, Ronghua Yin, Changyan Li, Chutse Wu, Xiaoming Yang, Miao Yu. HPS protects the liver against steatosis, cell death, inflammation, and fibrosis in mice with steatohepatitisThe FEBS Journal 2022; 289(17): 5279 doi: 10.1111/febs.16430
Jana Hundertmark, Oliver Krenkel, Frank Tacke. Adapted Immune Responses of Myeloid-Derived Cells in Fatty Liver DiseaseFrontiers in Immunology 2018; 9 doi: 10.3389/fimmu.2018.02418
Kook Hwan Kim, Myung-Shik Lee. Pathogenesis of Nonalcoholic Steatohepatitis and Hormone-Based Therapeutic ApproachesFrontiers in Endocrinology 2018; 9 doi: 10.3389/fendo.2018.00485
Cheng Ma, Cheng Wang, Yafang Zhang, Honglin Zhou, Yunxia Li. Potential Natural Compounds for the Prevention and Treatment of Nonalcoholic Fatty Liver Disease: A Review on Molecular MechanismsCurrent Molecular Pharmacology 2022; 15(6): 846 doi: 10.2174/1874467215666211217120448
Stergios A. Polyzos, Jannis Kountouras, Christos S. Mantzoros. Obesity and nonalcoholic fatty liver disease: From pathophysiology to therapeuticsMetabolism 2019; 92: 82 doi: 10.1016/j.metabol.2018.11.014
Y Ilan, K Shailubhai, A Sanyal. Immunotherapy with oral administration of humanized anti-CD3 monoclonal antibody: a novel gut-immune system-based therapy for metaflammation and NASHClinical and Experimental Immunology 2018; 193(3): 275 doi: 10.1111/cei.13159
Jared S. Farrar, Rebecca K. Martin. Non-Alcoholic SteatohepatitisMethods in Molecular Biology 2022; 2455: 103 doi: 10.1007/978-1-0716-2128-8_10
Marco Arrese, Daniel Cabrera, Alexis M. Kalergis, Ariel E. Feldstein. Innate Immunity and Inflammation in NAFLD/NASHDigestive Diseases and Sciences 2016; 61(5): 1294 doi: 10.1007/s10620-016-4049-x
Safa Tahmasebi, Hassan Neishaboori, Davood Jafari, Elham Faghihzadeh, Abdolreza Esmaeilzadeh, Abbas Mirshafiey. The effects of guluronic acid (G2013), a new emerging treatment, on inflammatory factors in nonalcoholic steatohepatitis patients under in vitro conditionsImmunopharmacology and Immunotoxicology 2021; 43(5): 562 doi: 10.1080/08923973.2021.1954946
Manon Bourinet, Rodolphe Anty, Philippe Gual, Carmelo Luci. Roles of innate lymphoid cells in metabolic and alcohol-associated liver diseasesJHEP Reports 2023; : 100962 doi: 10.1016/j.jhepr.2023.100962
Guilherme R. Romualdo, Letícia Cardoso Valente, Jéssica Luri Hisano de Souza, Josias Rodrigues, Luís Fernando Barbisan. Modifying effects of 2,4-D and Glyphosate exposures on gut-liver-adipose tissue axis of diet-induced non-alcoholic fatty liver disease in miceEcotoxicology and Environmental Safety 2023; 268: 115688 doi: 10.1016/j.ecoenv.2023.115688
Maria Arconzo, Elena Piccinin, Antonio Moschetta. Increased risk of acute liver failure by pain killer drugs in NAFLD: Focus on nuclear receptors and their coactivatorsDigestive and Liver Disease 2021; 53(1): 26 doi: 10.1016/j.dld.2020.05.034
Feliciano Chanana Paquissi. Immune Imbalances in Non-Alcoholic Fatty Liver Disease: From General Biomarkers and Neutrophils to Interleukin-17 Axis Activation and New Therapeutic TargetsFrontiers in Immunology 2016; 7 doi: 10.3389/fimmu.2016.00490